v3.26.1
Stockholders' Equity
 6 Months Ended
Jul. 31, 2026
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Stock Repurchases
On September 1, 2023, our board of directors approved a stock repurchase program which authorized the repurchase from time to time of up to $500.0 million of our outstanding shares of Class A common stock. This authorization was originally scheduled to expire on March 1, 2025. On August 30, 2024, our board of directors authorized the repurchase of an additional $500.0 million of our Class A common stock. These authorizations were fulfilled during the first quarter of fiscal year 2027, and on March 5, 2026, our board of directors authorized the repurchase of an additional $500.0 million of our Class A common stock. The current authorization may be suspended or discontinued at any time and does not have a specified expiration date. Repurchases under the program may be effected through open market purchases, privately-negotiated transactions, or otherwise in accordance with applicable federal securities laws, including through Rule 10b5-1 trading plans and under Rule 10b-18 of the Exchange Act. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital.
We repurchased 22.8 million and 30.2 million shares of our Class A common stock at an average price of $11.28 and $10.87 per share (inclusive of brokerage commission) during the six months ended July 31, 2026 and 2025, respectively.
For the six months ended July 31, 2026 and 2025, we accrued $1.8 million and $2.4 million, respectively, of related excise tax pursuant to the Inflation Reduction Act of 2022, which is included in the cost of treasury stock on our condensed consolidated balance sheets.
Charitable Donations of Class A Common Stock
We have reserved 2.8 million shares of our Class A common stock to fund our social impact and environmental, social, and governance initiatives. We contributed 0.3 million shares of our Class A common stock during each of the six-month periods ended July 31, 2026 and 2025 to a donor-advised fund in connection with our Pledge 1% commitment. The aggregate fair values of the shares on the respective contribution dates of $3.0 million and $4.2 million were recorded within general and administrative expense in the condensed consolidated statements of operations for the six months ended July 31, 2026 and 2025, respectively.
Accumulated Other Comprehensive Income
For the six months ended July 31, 2026 and 2025, changes in the components of accumulated other comprehensive income (loss) were as follows (in thousands):
Foreign Currency Translation AdjustmentsUnrealized Gain (Loss) on Marketable SecuritiesAccumulated Other Comprehensive Income
Balance as of January 31, 2026$36,256 $345 $36,601 
Other comprehensive loss, net of tax(19,836)(2,108)(21,944)
Balance as of July 31, 2026$16,420 $(1,763)$14,657 

Foreign Currency Translation AdjustmentsUnrealized Loss on Marketable SecuritiesAccumulated Other Comprehensive (Loss) Income
Balance as of January 31, 2025$(4,518)$(372)$(4,890)
Other comprehensive income (loss), net of tax29,895 (258)29,637 
Balance as of July 31, 2025$25,377 $(630)$24,747